Randomized phase II study of S-1 dosing schedule for resected colorectal cancer

BACKGROUND: Postoperative adjuvant chemotherapy for patients with stage III Colorectal cancer (CRC) is now internationally accepted as standard care for improving patient outcomes. The Adjuvant Chemotherapy Trial of S-1 for Colorectal Cancer (ACTS-CC) confirmed the non-inferiority of S-1 to tegafur/...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Matsuda, Chu, Uemura, Mamoru, Nakata, Ken, Shingai, Tatsushi, Nishimura, Junichi, Hata, Taishi, Ikenaga, Masakazu, Takemasa, Ichiro, Mizushima, Tsunekazu, Kato, Takeshi, Ikeda, Masataka, Ohue, Masayuki, Murata, Kohei, Hasegawa, Junichi, Satoh, Taroh, Yamamoto, Hirofumi, Sekimoto, Mitsugu, Nezu, Riichiro, Doki, Yuichiro, Mori, Masaki
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4470361/
https://ncbi.nlm.nih.gov/pubmed/26036466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1476-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados